Accolade welcomes renalogic to trusted partner ecosystem

Partnership will drive cost savings for customers while providing high-touch services that improve health outcomes to members with chronic kidney disease (ckd).  seattle , oct. 15, 2024 /prnewswire/ -- accolade, inc. (nasdaq: accd) today announced that renalogic, the recognized industry leader that manages the human and financial costs of chronic kidney disease (ckd) for self-insured employers and their members, will join the company's trusted partner ecosystem, to offer its proven ckd risk management and dialysis cost containment solutions.
ACCD Ratings Summary
ACCD Quant Ranking